Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease
Shijun Yan(University of California, Irvine), George K. Tofaris(University of Oxford), Wolfgang H. Oertel(Philipps University of Marburg), Thomas R. Barber(University of Oxford), Michael Sommerauer(Forschungszentrum Jülich), Jason J. Davis(University of Oxford), Kenneth Marek(University of Pennsylvania), Aline Seger(Forschungszentrum Jülich), Cheng Jiang(University of Oxford), Annette Janzen(Philipps University of Marburg)
Cited by 114
Related Papers
The natural history of multiple system atrophy: a prospective European cohort study
|The Lancet Neurology|2013|533
Unilateral Transplantation of Human Fetal Mesencephalic Tissue into the Caudate Nucleus of Patients with Parkinson's Disease
|New England Journal of Medicine|1992|516
PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer’s disease
|Brain|2017|301
The immobilisation of proteins in carbon nanotubes
|Inorganica Chimica Acta|1998|263
Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder
|The Lancet Neurology|2021|239